Orchestra BioMed Holdings, Inc. (OBIO) vs Surrozen, Inc. (SRZN)
Orchestra BioMed Holdings, Inc. and Surrozen, Inc. are both Biotechnology companies. Orchestra BioMed Holdings, Inc. and Surrozen, Inc. are of similar size ($386.6M and $366.0M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against −8.79%. Orchestra BioMed Holdings, Inc. has the higher net margin (−186.3% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Orchestra BioMed Holdings, Inc. leads on 10 and Surrozen, Inc. on 5.
Valuation
Profitability
| Metric | OBIO | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.51% | 100.00% | 65.16% |
| Operating margin | (181.36%) | (385.28%) | 0.00% |
| Net margin | (186.30%) | (2,887.07%) | 0.00% |
| Free cash flow margin | (184.83%) | (303.92%) | 0.00% |
| Return on equity | (607.32%) | 387.44% | (57.72%) |
| Return on assets | (75.16%) | (304.47%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack